CHILDREN'S ADVIL-FLAVORED Drug Patent Profile
✉ Email this page to a colleague
When do Children's Advil-flavored patents expire, and what generic alternatives are available?
Children's Advil-flavored is a drug marketed by Glaxosmithkline and is included in one NDA. There is one patent protecting this drug.
This drug has nine patent family members in eight countries.
The generic ingredient in CHILDREN'S ADVIL-FLAVORED is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and eight suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Children's Advil-flavored
A generic version of CHILDREN'S ADVIL-FLAVORED was approved as ibuprofen by OHM on July 15th, 1986.
Summary for CHILDREN'S ADVIL-FLAVORED
| International Patents: | 9 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 184 |
| Clinical Trials: | 8,704 |
| Patent Applications: | 4,338 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CHILDREN'S ADVIL-FLAVORED at DailyMed |
Recent Clinical Trials for CHILDREN'S ADVIL-FLAVORED
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| George Washington University | Phase 2 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Phase 1 |
| Eurofarma Laboratorios S.A. | Phase 3 |
Pharmacology for CHILDREN'S ADVIL-FLAVORED
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for CHILDREN'S ADVIL-FLAVORED
US Patents and Regulatory Information for CHILDREN'S ADVIL-FLAVORED
CHILDREN'S ADVIL-FLAVORED is protected by one US patents.
Patents protecting CHILDREN'S ADVIL-FLAVORED
Pharmaceutical suspension composition
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | CHILDREN'S ADVIL-FLAVORED | ibuprofen | SUSPENSION;ORAL | 020589-002 | Nov 7, 1997 | OTC | No | No | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for CHILDREN'S ADVIL-FLAVORED
See the table below for patents covering CHILDREN'S ADVIL-FLAVORED around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| South Korea | 960012062 | See Plans and Pricing | |
| World Intellectual Property Organization (WIPO) | 2005115353 | See Plans and Pricing | |
| Australia | 608023 | See Plans and Pricing | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2022 - 2023
NCE-1 Patent Challenge Dates 2022 - 2023
ClinicalTrialExchange - Connecting volunteers and trials
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2022, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
